Conjuchem Inc.

Other News To Note.
BIOWORLD Today; 11/4/2009; 1740 words; ...common shares. Rodman & Renshaw Inc., of New York, acted as exclusive...or premium for early repayment. o ConjuChem Inc., of Montreal, said the FDA cleared...be monitored seven times daily. ConjuChem, which also is studying the compound...

Patent No. 7,608,271 Issued on Oct. 27, Assigned to Conjuchem Biotechnologies for Modified Human Immunodeficiency Virus (U.S., Canadian Inventors)
US Fed News Service, Including US State News; 11/4/2009; 440 words; ...The inventors were issued U.S. Patent No. 7,608,271 on Oct. 27. The patent has been assigned to Conjuchem Biotechnologies Inc., Quebec. According to the abstract released by the U.S. Patent & Trademark Office: "Peptides...

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1469 words; o ConjuChem Biotechnologies Inc., of Montreal, said it will be presenting...2007.) o Javelin Pharmaceuticals Inc., of Cambridge, Mass., said results...analyses are ongoing. o Lorus Therapeutics Inc., of Toronto, said enrollment is under...

Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 1378 words; ...Robert Forbes Burns CEO. Cephalon Inc., of Frazer, Pa., appointed Kevin...development and quality assurance. ConjuChem Inc., of Montreal, appointed Thomas...technologies industry teams. Genentech Inc., of South San Francisco, appointed...

Nausea Taints ConjuChem's Diabetes Drug Phase II Trial.
BIOWORLD Today; 11/3/2009; 1325 words; ...trial taking about two years, ConjuChem could file with regulatory...sometime in 2007. The only reason ConjuChem might not move into the Phase...often. Amylin Pharmaceuticals Inc.'s exenatide is dosed twice...BioWorld Today, July 1, 2004.) ConjuChem's Phase II trial, which...